|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. PubMed PMID: 37368200.
AÑO: 2024; IF: 2.8
|
37368200
|
Hidalgo-Gomez G, Minguela A, Tazon-Vega B, Ribera J, Galian JA, Martinez-Banaclocha H, Garcia-Garay M, Velasco P, Fuster-Soler JL, Armengol G, Ortega M. Clonal heterogeneity and genomic evolution in intrachromosomal amplification of chromosome 21: A case report. Br J Haematol. 2024 Jun;204(6):2512-2515. doi: 10.1111/bjh.19485. Epub 2024 Apr 26. No abstract available. PubMed PMID: 38665061.
AÑO: 2024; IF: 5.1
|
|
Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Gonzaalez Martinez B, Fuentes C, Molinos A, Guerra-Garcia P, Palomo P, Verdu J, Adan Pedroso RM, Vagace JM, Lopez-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta A, Lendinez F, Rives S, Pascual A, Rodriguez A, Perez-Hurtado JM, Fernandez JM, Perez-Martinez A, Gonzalez-Vicent M, Diaz de Heredia C, Fuster JL. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet). Front Pediatr. 2023 Mar 20;11:1140637. doi: 10.3389/fped.2023.1140637. eCollection 2023. PubMed PMID: 37020654; PubMed Central PMCID: PMC10067875.
AÑO: 2023; IF: 2.1
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 May;25(5):1446-1454. doi: 10.1007/s12094-022-03042-z. Epub 2023 Jan 4. PubMed PMID: 36598635.
AÑO: 2023; IF: 2.8
|
|
Cabrera-Rivera LT, Sweetser B, Fuster-Soler JL, Ramis R, Lopez-Hernandez FA, Perez-Martinez A, Ortega-Garcia JA. Looking Towards 2030: Strengthening the Environmental Health in Childhood-Adolescent Cancer Survivor Programs. Int J Environ Res Public Health. 2022 Dec 27;20(1):443. doi: 10.3390/ijerph20010443. PubMed PMID: 36612765; PubMed Central PMCID: PMC9819016.
AÑO: 2022
|